Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion type Assertion NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_head.
- NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion description "[We measured serum levels of total alkaline phosphatase activity, osteocalcin, carboxy-terminal propeptide of human type I procollagen (PICP), tartrate-resistant acid phosphatase activity (TRAP), and the fasting urinary hydroxyproline/creatinine ratio (OHPr/Cr) in seven affected members (four men, three women; age, 43.3 +/- 16.6 years [mean +/- SD]) of a family with clinically diagnosed type I-A osteogenesis imperfecta (OI) and in eight (five men, three women) normal age-matched (38.2 +/- 10.3) relatives.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_provenance.
- NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion evidence source_evidence_literature NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_provenance.
- NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion SIO_000772 7934978 NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_provenance.
- NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion wasDerivedFrom befree-20150227 NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_provenance.
- NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_assertion wasGeneratedBy ECO_0000203 NP221240.RAWRTDiIhuJ43AlMOaHXrpi_16F2tBso2OhFbzn-eIPhE130_provenance.